AKIN TELLİ, T. Et Al. 2022. Role of baseline Ga-68-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatment. ANNALS OF NUCLEAR MEDICINE , vol.36, no.11 , 964-975.

AKIN TELLİ, T., ÖZGÜVEN, S., Alan, O., Filizoglu, N., ÖZTÜRK, M. S., Sariyar, N., ... Isik, S.(2022). Role of baseline Ga-68-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatment. ANNALS OF NUCLEAR MEDICINE , vol.36, no.11, 964-975.

AKIN TELLİ, TUĞBA Et Al. "Role of baseline Ga-68-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatment," ANNALS OF NUCLEAR MEDICINE , vol.36, no.11, 964-975, 2022

AKIN TELLİ, TUĞBA A. Et Al. "Role of baseline Ga-68-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatment." ANNALS OF NUCLEAR MEDICINE , vol.36, no.11, pp.964-975, 2022

AKIN TELLİ, T. Et Al. (2022) . "Role of baseline Ga-68-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatment." ANNALS OF NUCLEAR MEDICINE , vol.36, no.11, pp.964-975.

@article{article, author={TUĞBA AKIN TELLİ Et Al. }, title={Role of baseline Ga-68-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatment}, journal={ANNALS OF NUCLEAR MEDICINE}, year=2022, pages={964-975} }